Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Rifaximin[1] Rifaximin[1] D02554 (Name: Rifaximin)--[7] 6, 65, 93, 96, 97, 99, 296
2Rifaximin 550 MG[1] Rifaximin[1] D02554 (Name: Rifaximin)--[1] 6
3Rifaximin Delayed Release (DR)[1] Rifaximin[1] D02554 (Name: Rifaximin)--[1] 96
4Rifaximin delayed release 400 mg film coated tablet[1] Rifaximin[1] D02554 (Name: Rifaximin)--[1] 96
5Rifaximin delayed release tablets[1] Rifaximin[1] D02554 (Name: Rifaximin)--[1] 96
6Rifaximin EIR[1] Rifaximin[1] D02554 (Name: Rifaximin)--[1] 96
7Rifaximin oral tablet[1] Rifaximin[1] D02554 (Name: Rifaximin)--[1] 99
8Rifaximin+omeprazole+miralax[2] Omeprazole,
Rifaximin		[5] D00455 ,
D01207 ,
D02554 (Name: Rifaximin),
D05259 ,
D05261 		[2] ATP4A,
ATP4B 💬		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[1] 96
9Rifaximin-EIR[1] Rifaximin[1] D02554 (Name: Rifaximin)--[1] 96
10RIFAXIMINA[1] Rifaximin[1] D02554 (Name: Rifaximin)--[1] 96
11Sodium phosphate enema, oral rifaximin and polyethylene glycol[3] Phosphate ion,
Polyethylene glycol,
Rifaximin		[2] D02554 (Name: Rifaximin),
D03370 		--[1] 6